Acute pancreatitis in liver transplant hospitalizations: Identifying national trends, clinical outcomes and healthcare burden in the United States

Table 5 Predictors of inpatient mortality for liver transplant hospitalizations with acute pancreatitis in the United States from 2007–2019

Variable	Adjusted hazard ratio	95%CI	P value
Gender
Male	Reference
Female	0.596	(0.150, 2.365)	0.461
Race
White	Reference
Black	0.306	(0.017, 5.368)	0.418
Hispanic	< 0.001	(< 0.001, < 0.001)	< 0.0001
Asian	0.042	(< 0.001, 14.916)	0.289
Other	0.064	(< 0.001, 10.989)	0.295
Charlson comorbidity index	1.678	(1.055, 2.668)	0.029
Hospital region
Northeast	Reference
Midwest	1.574	(0.148, 16.692)	0.706
South	1.435	(0.230, 8.955)	0.699
West	1.723	(0.423, 7.014)	0.447
Hospital bed size
Small	Reference
Medium	1.427	(0.093, 21.893)	0.798
Large	1.974	(0.093, 42.139)	0.663
Hospital location and teaching status
Rural	Reference
Urban nonteaching	< 0.001	(< 0.001, 0.048)	0.003
Urban teaching	0.551	(0.053, 5.689)	0.617
Complications (reference = Without the complication)
Pancreatic psuedocyst	14.158	(1.642, 122.094)	0.016
Abdominal abscess	< 0.001	(< 0.001, < 0.001)	< 0.0001
Sepsis	13.960	(2.163, 90.093)	0.006
Acute renal failure	2.684	(1.109, 6.494)	0.029
Acute respiratory failure	24.758	(1.063, 576.522)	0.046
Need for blood transfusion	150.340	(17.049, 1325.754)	< 0.0001
Portal vein thrombosis	< 0.001	(< 0.001, < 0.001)	< 0.0001
Venous thromboembolism	75.422	(1.637, 3475.134)	0.027